Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX415 in Essential Hypertension
NCT00779181Phase 2Completed
- Sponsor
- Addrenex Pharmaceuticals
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adx415 in hypertension (HTN), sponsored by Addrenex Pharmaceuticals. Started Oct 2008; status: completed.
02
Drugs
adx415
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00779181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779181.